Ex-Nomura Quant Says in Bias Suit She Was Faulted for Biopsy (1)

Jan. 23, 2024, 9:41 PM UTC

A former Nomura Holdings Inc. quantitative researcher sued the firm for gender bias, claiming she was penalized for not rescheduling a series of breast cancer screenings so she could be in the office.

Xue “Heidi” Feng alleges in a lawsuit filed Monday in New York federal court that Nomura’s failure to accommodate “health issues that are specific to women” was part of a pattern of discriminatory treatment. She claims she was consistently paid less than male peers, excluded from meetings and then singled out for termination in July.

A Nomura spokesman said Feng’s suit has no merit and she was ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.